Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,759 | 355 | 50.6% |
| Consulting Fee | $5,156 | 5 | 24.3% |
| Travel and Lodging | $3,575 | 20 | 16.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $980.00 | 1 | 4.6% |
| Honoraria | $500.00 | 1 | 2.4% |
| Education | $276.90 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $8,298 | 42 | $0 (2024) |
| Boston Scientific Corporation | $2,704 | 59 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,332 | 43 | $0 (2020) |
| Medtronic, Inc. | $1,694 | 46 | $0 (2024) |
| Wilson Cook Medical Incorporated | $980.00 | 1 | $0 (2023) |
| Biosense Webster, Inc. | $644.14 | 20 | $0 (2024) |
| AltaThera Pharmaceuticals LLC | $500.00 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $484.47 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $455.71 | 24 | $0 (2024) |
| PFIZER INC. | $363.33 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,779 | 101 | Abbott Laboratories ($1,357) |
| 2023 | $3,777 | 124 | Wilson Cook Medical Incorporated ($980.00) |
| 2022 | $2,511 | 40 | Abbott Laboratories ($925.60) |
| 2021 | $1,959 | 27 | Abbott Laboratories ($1,599) |
| 2020 | $3,983 | 18 | Abbott Laboratories ($3,829) |
| 2019 | $921.39 | 20 | Medtronic Vascular, Inc. ($711.65) |
| 2018 | $2,371 | 33 | Medtronic Vascular, Inc. ($1,083) |
| 2017 | $1,945 | 22 | BOSTON SCIENTIFIC CORPORATION ($1,107) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $198.80 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/16/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $60.35 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/16/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $128.73 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/25/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Pacemakers | ||||||
| 11/22/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Electrophysiology | ||||||
| 11/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/09/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $306.93 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/09/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $124.11 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/09/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $116.18 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/09/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $51.97 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/04/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Pacemakers | ||||||
| 10/30/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $170.55 | General |
| Category: Pacemakers | ||||||
| 10/30/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/18/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: Pacemakers | ||||||
| 09/12/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/09/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 1,706 | 3,143 | $744,362 | $276,195 |
| 2022 | 31 | 2,292 | 3,488 | $724,005 | $196,027 |
| 2021 | 37 | 2,090 | 3,171 | $738,821 | $202,216 |
| 2020 | 36 | 1,618 | 2,488 | $612,314 | $170,394 |
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 683 | $153,935 | $69,421 | 45.1% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 12 | 12 | $52,800 | $20,914 | 39.6% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 18 | 19 | $43,748 | $15,017 | 34.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 142 | $30,652 | $14,385 | 46.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 81 | 81 | $39,497 | $13,934 | 35.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 19 | 19 | $24,868 | $13,406 | 53.9% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 12 | 24 | $49,968 | $10,018 | 20.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 64 | 227 | $25,878 | $9,893 | 38.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 60 | 64 | $26,802 | $9,369 | 35.0% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 11 | 12 | $22,638 | $9,260 | 40.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 23 | 51 | $29,035 | $9,226 | 31.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 55 | 161 | $23,667 | $7,635 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $20,836 | $7,460 | 35.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 41 | $12,407 | $6,080 | 49.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 38 | 296 | $16,286 | $5,851 | 35.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 61 | 87 | $10,736 | $5,639 | 52.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $12,019 | $5,036 | 41.9% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 13 | 19 | $17,459 | $4,860 | 27.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 12 | 12 | $12,682 | $4,604 | 36.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 72 | 193 | $13,595 | $4,305 | 31.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 234 | 337 | $12,078 | $3,973 | 32.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 21 | 84 | $9,289 | $3,726 | 40.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 34 | 93 | $13,074 | $2,727 | 20.9% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 16 | 29 | $5,548 | $2,639 | 47.6% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 33 | 54 | $3,576 | $2,515 | 70.3% |
About Dr. Jashdeep Dhoot, M.D
Dr. Jashdeep Dhoot, M.D is a Cardiovascular Disease healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1417109067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jashdeep Dhoot, M.D has received a total of $21,247 in payments from pharmaceutical and medical device companies, with $3,779 received in 2024. These payments were reported across 385 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($10,759).
As a Medicare-enrolled provider, Dhoot has provided services to 7,706 Medicare beneficiaries, totaling 12,290 services with total Medicare billing of $844,832. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Torrance, CA
- Active Since 10/15/2008
- Last Updated 09/13/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417109067
Products in Payments
- Nanostim Leadleas Pacemaker (Device) $3,484
- Confirm Rx (Device) $1,540
- AVEIR (Device) $1,418
- MICRA (Device) $1,176
- EVOLUTION (Device) $980.00
- WATCHMAN (Device) $954.48
- Micra (Device) $903.92
- GENERAL - THERAPIES (Device) $845.03
- CONFIRM RX (Device) $750.00
- CARTO 3 (Device) $538.34
- Sotalol Hydrochloride (Drug) $500.00
- LEQVIO (Drug) $427.31
- Azure (Device) $378.93
- Amplia MRI (Device) $352.51
- LifeVest (Device) $341.60
- FARXIGA (Drug) $305.48
- Tendril Pacing Lead (Device) $281.25
- VERQUVO (Drug) $267.92
- ELIQUIS (Drug) $250.68
- XARELTO (Drug) $246.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Torrance
Matthew Budoff, M.d, M.D
Cardiovascular Disease — Payments: $5.0M
Ronald Oudiz, M.d, M.D
Cardiovascular Disease — Payments: $836,408
Dr. Rishi Kaushal, M.d, M.D
Cardiovascular Disease — Payments: $108,970
Dr. Matthew Ostrom, M.d, M.D
Cardiovascular Disease — Payments: $57,874
Joseph Thomas, Md, MD
Cardiovascular Disease — Payments: $52,485
Dr. Leonard Scuderi, M.d, M.D
Cardiovascular Disease — Payments: $42,878